{"id":839868,"date":"2025-04-22T07:34:38","date_gmt":"2025-04-22T11:34:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/"},"modified":"2025-04-22T07:34:38","modified_gmt":"2025-04-22T11:34:38","slug":"bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/","title":{"rendered":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PALO ALTO, Calif., April  22, 2025  (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter financial results and program updates after the market closes on Tuesday, April 29, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. <\/p>\n<p align=\"left\">To access the live webcast of BridgeBio\u2019s presentation, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kvd2MJSQnf4mXPRe35ZvGXncgjxg-cu2ZyHgH-Lnflk5tmkcqgiOLLFz1sgHpHOn3chYsDSJnEsRrzKeHwv3SkUm1IsK3-1tU7s3_APQ1LLoVpJvFd9pTYQvRkoTJf0E1C_Db8C7fJAvkqeMDYTCJmpqnoWHlcdtdNAv3QdgqCzOaJDtI3X9a1p0uZSChi_KCkwxluFx1sk1jBJ31vkHbQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.bridgebio.com\/news-and-events\/event-calendar<\/a>. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.<\/p>\n<p>Participants may access the webcast by registering online using the following link, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kvd2MJSQnf4mXPRe35ZvGQYYF6PokqwtqC3vdjVmtADAT_KPeY7wiwi2caUtptmtqTieyJ5QHzrfgxXN2cr-31mYNmO0r2h9ZJSmsN8NhgvEXsaphzcMLcv_g8fyswaoSNXNf_AwXN6VpSTiRZpZT35da68yT_wMxa76OgyL-kU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/events.q4inc.com\/attendee\/682276610<\/a>.<\/p>\n<p>\n        <strong>About BridgeBio Pharma, Inc.<\/strong><br \/>\n        <br \/>BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio\u2019s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gafA7dWymLmiOGaLAj00Yy7M4DMYk2h0DyEODy8EvQT0t8nZGUOzP5cclAMgh43HBGankbrFRkzrbHqJd98Ff_qAffs6Z3WP2pID6pwc0ssJbzGN1j2_UM3LcaALQ_q5-ZIJfd_VZBT1WWlAAwxud7hAJgPsrCsTkaN3UulA7pu4yMllhmVR9j1-PLH7EM4PetFY_mVjvkNsoV3ZtmEFt0DWPDp8EUhA8VEKCGAoLb8=\" rel=\"nofollow\" target=\"_blank\"><strong>bridgebio.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0IFa3vRmDMI0iaG0YSN6sT60pqVC9uYKjroFvYIrqmoibqsiAkz8FiRbZEBZrK_OW9AB5_0oFK3Rcvp2zxusCKV1bWGsNiDulmeocQiNbAg4C4wMo_ETSu33ZRHHmCdBEgeS9oAFoK3m9fEVN7uMxUdIwotEdj1Gtfb-vqCvpG3vi6K7o2RdLUctlGE4i_fC6hgg5z7JbjJlxPQgSgckEyZeBF_e3s867w48NW-WNh_j_qukHwu5vFQujEIrwzeX\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a><strong>, <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VCTSAe0uIH9i6b48BisGZMHy3V257uCeX4uVYkwDYOA0_T5DsYHLUX336R0h5tg-sJXA73qE2zaTAOxoRd4jgSbbyldCUs14fU1SQPx8WeMttr6hGC6NrZ8yYKnFzo8o5_Pj-_720Kzzivs3Zz-YxdldebtHnNaHZo-GppjiuzzIHAWfCqqikkNtrjOoJQUVBnjPYQvOPlHRnm8QRbwzjANlwG_o6seLkKZ8VpI72xMmbXBluUSrE-xXhDEMUHV6\" rel=\"nofollow\" target=\"_blank\"><strong>Twitter<\/strong><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l7ynBHotjZJRs_TxrohIreOi9njRqiqdppQSRaqV_jVIYYYc__dXm28BYQ3isuH4ENUljUQiQCHHZcSSs3wK8FTH_Ze_w7NMcZjZ_zCgoMVObUN3KxFzW216YSfKK0kiGuPN1lAGh4Vutio6C5g933z51o7ppjMLX2R6wU62dWoHMyO8fa6ufpDdB4YrGVw5ozdhAI4kL1bO8fk6F9C99aXimKmCKNmefjNa-gcEf90gV3vGvds_ePG6l-TlCo4rAewb7AeJGXjyryA-zoKLZA==\" rel=\"nofollow\" target=\"_blank\"><strong>Facebook<\/strong><\/a>.<\/p>\n<p>\n        <strong>BridgeBio Contact:<\/strong><br \/>\n        <br \/>Bubba Murarka, EVP Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q4NW1YjoaGUZwLcxZKG-kdx_P5vUO_jAcznoIMkYf3ZqCnVL0RzW9_x5TSxuDlfOrs-QZIv-rg1EUOJlqKJPBShkzvin3Ld-BEvWXGyQDDPlg2NXi5UOw1VR2EeTFr1deIZ2MEoq-k6TiCYAQqJbTWLoNyS8tOmnlvSZNdFU67ySzBsTBAcbrWEijg_c-B6MbpV192x4A8yA8B26S1NGBae7hlI9BTghDbfoPZoNKmVLFj91XKpefyCqrG_GIW4BwM07bkFoAFCCzllUDyCdmg==\" rel=\"nofollow\" target=\"_blank\">contact@bridgebio.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qFlvK9eFa0Wq6W8RJRGwwYhtRG7CjttDewD2QjhYRPwVaMtti0dSsN02jPGUeuuN5yRPz8fG7T9WrpYZ7n_JL_1-lxi6yI89RgAxHYKrF20Zziw6Awxw0xONEW7jhaR6gKsg0t8PvE4avPQFIARxXjtfzPTnGBSlyrKoDuSHIYXMZIiWzz5WWFwamU4j_tVvyZ_5cSgbwmYHbPFl8oodchZA3yJ2oy2fbVpdwrJqWL9lF_qLo60fB_M82D1VJ_m7\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>(650)-789-8220<\/p>\n<p>Chinmay Shukla, VP Strategic Finance<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DT3UcTB28HQc_tsckpJR5wufHBB42ZpxevWn4AmSOwG8MsT4nx05GOcU4Sli78YUayeMY6uOrJxUoJ-lN7Yl-B7aKNhlF7LIvY_ufsg-C5g=\" rel=\"nofollow\" target=\"_blank\">IR@bridgebio.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTZkZDI2MDgtMTNlMi00ZWNjLTgzMmYtNWIxZDE0YjU3ZTdhLTExNjg0OTctMjAyNS0wNC0yMi1lbg==\/tiny\/BridgeBio-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter financial results and program updates after the market closes on Tuesday, April 29, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. To access the live webcast of BridgeBio\u2019s presentation, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com\/news-and-events\/event-calendar. A replay of the webcast will be available on the BridgeBio website for 30 days following the event. Participants may access the webcast by registering &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-839868","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter financial results and program updates after the market closes on Tuesday, April 29, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. To access the live webcast of BridgeBio\u2019s presentation, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com\/news-and-events\/event-calendar. A replay of the webcast will be available on the BridgeBio website for 30 days following the event. Participants may access the webcast by registering &hellip; Continue reading &quot;BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-22T11:34:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET\",\"datePublished\":\"2025-04-22T11:34:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/\",\"name\":\"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\",\"datePublished\":\"2025-04-22T11:34:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk","og_description":"PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its first quarter financial results and program updates after the market closes on Tuesday, April 29, 2025. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. To access the live webcast of BridgeBio\u2019s presentation, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com\/news-and-events\/event-calendar. A replay of the webcast will be available on the BridgeBio website for 30 days following the event. Participants may access the webcast by registering &hellip; Continue reading \"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-22T11:34:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET","datePublished":"2025-04-22T11:34:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/","name":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=","datePublished":"2025-04-22T11:34:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzNjE1OCM2ODk2MTM1IzIxNTY5MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-host-first-quarter-2025-financial-results-conference-call-on-tuesday-april-29-2025-at-430-pm-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio to Host First Quarter 2025 Financial Results Conference Call on Tuesday, April 29, 2025 at 4:30 pm ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=839868"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/839868\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=839868"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=839868"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=839868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}